Priyanka Rohatgi is a Venture Partner at Longwood Fund. She was recently Managing Director and Head of Ipsen Ventures where she was responsible for managing limited partnerships, Ipsen Innovation Center, and direct investments in innovative biotech companies in oncology and rare diseases. Previously she was an investment director at two strategic venture funds, AbbVie Ventures and Baxter Ventures. She has been investing in therapeutics and medical devices for several years in various therapeutic areas of oncology, immunology, renal, and neurodegenerative diseases. She has led many investments, spun out companies from academic institutions and built an accelerator which had a unique build-to-buy model for Baxter. She previously served as a board observer/member with Syntimmune, Opsonix, Sanifit, Naurex, Mirna, Artios, Pyxis Oncology, and Xilio Therapeutics.
Prior to venture capital, Priyanka was with Baxter R&D in the drug metabolism and clinical pharmacology leading multi-disciplinary teams. Priyanka was a postdoctoral fellow in the School of Pharmacy at University of Washington. She has a PhD in Biochemistry and Masters in bioinformatics from the Georgia Institute of Technology, Masters in Pharmaceutics from the University of Washington, Masters in Biology from the Indiana University of Pennsylvania, and a Bachelor of Science from the University of Delhi.